Impact of Biofluid Viscosity on Size and Sedimentation Efficiency of the Isolated Microvesicles

Microvesicles are nano-sized lipid vesicles released by all cells in vivo and in vitro. They are released physiologically under normal conditions but their rate of release is higher under pathological conditions such as tumors. Once released they end up in the systemic circulation and have been found and characterized in all biofluids such as plasma, serum, cerebrospinal fluid, breast milk, ascites, and urine. Microvesicles represent the status of the donor cell they are released from and they are currently under intense investigation as a potential source for disease biomarkers. Currently, the “gold standard” for isolating microvesicles is ultracentrifugation, although alternative techniques such as affinity purification have been explored. Viscosity is the resistance of a fluid to a deforming force by either shear or tensile stress. The different chemical and molecular compositions of biofluids have an effect on its viscosity and this could affect movements of the particles inside the fluid. In this manuscript we addressed the issue of whether viscosity has an effect on sedimentation efficiency of microvesicles using ultracentrifugation. We used different biofluids and spiked them with polystyrene beads and assessed their recovery using the Nanoparticle Tracking Analysis. We demonstrate that MVs recovery inversely correlates with viscosity and as a result, sample dilutions should be considered prior to ultracentrifugation when processing any biofluids.

[1]  T. Oosterkamp,et al.  Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics , 2012, Biomedical Microdevices.

[2]  Josiah Ochieng,et al.  Detachment of Breast Tumor Cells Induces Rapid Secretion of Exosomes Which Subsequently Mediate Cellular Adhesion and Spreading , 2011, PloS one.

[3]  Hamid Cheshmi Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[4]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[5]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[6]  R. Bertina,et al.  Pre-analytical and analytical issues in the analysis of blood microparticles , 2010, Thrombosis and Haemostasis.

[7]  W. Zacharias,et al.  Exosome isolation for proteomic analyses and RNA profiling. , 2011, Methods in molecular biology.

[8]  M Ala-Korpela,et al.  Detection of low density lipoprotein particle fusion by proton nuclear magnetic resonance spectroscopy. , 1998, Journal of lipid research.

[9]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[10]  R. Rosenson,et al.  Postprandial changes in plasma and serum viscosity and plasma lipids and lipoproteins after an acute test meal. , 1997, The American journal of clinical nutrition.

[11]  K. Bailey,et al.  Alterations in Platelet Function and Cell-Derived Microvesicles in Recently Menopausal Women: Relationship to Metabolic Syndrome and Atherogenic Risk , 2011, Journal of cardiovascular translational research.

[12]  P. Altevogt,et al.  Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.

[13]  N. Aoki,et al.  Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. , 2010, Biochemical and biophysical research communications.

[14]  A. Glatfelter,et al.  Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[15]  Crislyn D'Souza-Schorey,et al.  Microvesicles: mediators of extracellular communication during cancer progression , 2010, Journal of Cell Science.

[16]  A. Dalton Microvesicles and vesicles of multivesicular bodies versus "virus-like" particles. , 1975, Journal of the National Cancer Institute.

[17]  G. Camussi,et al.  Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. , 2011, Cancer research.

[18]  Richard J Simpson,et al.  Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.

[19]  V. Bond,et al.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. , 2011, AIDS research and human retroviruses.

[20]  J. Fahey,et al.  SERUM HYPERVISCOSITY SYNDROME. , 1965, JAMA.

[21]  R. Wattiaux,et al.  Deterioration of rat-liver mitochondria during centrifugation in a sucrose gradient. , 1971, European journal of biochemistry.

[22]  M. Rubin,et al.  Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. , 2009, Cancer research.

[23]  D. Scott,et al.  Analytical Ultracentrifugation: Techniques and Methods , 2007 .

[24]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[25]  V. Miller,et al.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood. , 2012, Journal of immunological methods.

[26]  H. Hägerstrand,et al.  Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process , 2011, International journal of nanomedicine.

[27]  G. Escolar,et al.  Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. , 1984, Blood.